Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07503886 · ClinicalTrials.gov registry record · Phase 2
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
A Phase 2 study, sponsored by Dompé Farmaceutici S.p.A.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 417
- Enrollment target
NCT07503886 is a Phase 2 study that is actively recruiting participants, run by Dompé Farmaceutici S.p.A. The registered enrollment target is 417 participants.
The verdict
NCT07503886, a Phase 2 study, is actively recruiting participants, sponsored by Dompé Farmaceutici S.p.A.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 417 participants
- Enrollment target
Study Summary
This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in participants with dry eye disease. Approximately 417 participants aged 18 years or older who meet all eligibility criteria will be enrolled at study sites in the US. The study duration will be up to 16 weeks and will consist of three periods.
Interventions
- OTHER Vehicle
- DRUG DFL24498
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2026-05-12 |
| Est. Completion | 2027-02-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07503886
The ClinicalTrials.gov registry entry for NCT07503886 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 417 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dompé Farmaceutici S.p.A, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT07503886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07503886 about?
NCT07503886 is a clinical study titled "An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease". This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in participants with dry eye disease. Approximately 417 participants aged 18 years or older who meet all elig...
What is the current status of trial NCT07503886?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 417 participants. The study started on 2026-05-12. Estimated completion is 2027-02-07.
What interventions are being tested in trial NCT07503886?
The interventions under investigation include: Vehicle (OTHER), DFL24498 (DRUG).
Who is sponsoring clinical trial NCT07503886?
This trial is sponsored by Dompé Farmaceutici S.p.A, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.